Companies List
>> Barr Pharmaceuticals
Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide. The Company’s operations are based primarily in North America and Europe, with key markets being the United States, Croatia, Germany, Poland and Russia. It is primarily engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals. The Company's generic product portfolio includes solid oral dosage forms, injectables and cream/ointment products. The Company markets and sells proprietary pharmaceutical products primarily in the United States through its Duramed Pharmaceuticals (Duramed) subsidiary. Its proprietary product portfolio and pipeline is concentrated in the area of female healthcare.
Official website:
www.barrlabs.com
|
|
 |
|
USA stock market daily report by Millenium Traders (October 9, 2008, Thursday, 10.30 p.m. GMT), 9 October 2008
USA stock market daily report by Millenium Traders (October 8, 2008, Wednesday, 10.30 p.m. GMT), 8 October 2008
USA stock market daily report by Millenium Traders (October 7, 2008, Tuesday, 10.30 p.m. GMT), 7 October 2008
|
|
Verint Systems price target reduced, 7 December 2007
Thomas Weisel upgraded Intel to "overweight", 6 December 2007
UBS upgraded price target on Exxon Mobil to $96, 21 November 2007
|
|
|
|
|
|
 |
|
Indian stock market morning report by Keynote Capitals (October 10, 2008, Friday, 7.00 a.m. GMT), 10 October 2008
Indian stock market morning report by Keynote Capitals (October 8, 2008, Wednesday, 7.00 a.m. GMT), 8 October 2008
Indian stock market morning report by Keynote Capitals (October 7, 2008, Tuesday, 6.00 a.m. GMT), 7 October 2008
|
|
Keynote Capitals maintain "buy" recommendation on Pyramid Saimira Theatre, 5 February 2008
Keynote Capitals recommends to buy Euro Ceramics Ltd., 5 February 2008
Keynote Capitals recommends to buy Pyramid Saimira Theatre, 13 December 2007
|
|
|
|
|
|
 |
|
Russian stock market morning report by Veles Capital (October 8, 2008, Wednesday, 7.30 a.m. GMT), 8 October 2008
Russian stock market morning report by Veles Capital (October 7, 2008, Tuesday, 7.30 a.m. GMT), 7 October 2008
Russian stock market morning report by Veles Capital (October 6, 2008, Monday, 7.30 a.m. GMT), 6 October 2008
|
|
Veles Capital upgraded price target on Rosneft from $14.31 to $15.11, recommendation "buy" unchanged, 18 September 2008
Veles Capital set price target of $5.75 on NLMK, recommenation - "buy", 17 September 2008
Veles Capital reduced price target on Lukoil from $138.44 to $129.63, recommendation "buy" unchanged, 15 September 2008
|
|
|
|
|
|
